Hims & Hers Health, Inc.
Hims & Hers Health Appoints New Board Member
Summary
On March 30, 2024, Hims & Hers Health, Inc. appointed Christopher Payne as a new member of its Board of Directors, expanding the board from nine to ten directors. Mr. Payne, aged 55, will serve until the Company's 2024 annual meeting of stockholders or until his successor is elected and qualified. The Board has determined that Mr. Payne meets the independence requirements under the New York Stock Exchange and the Securities Exchange Act of 1934. His compensation will be in accordance with the Company's director compensation program, with an initial award of restricted stock units valued at $400,000.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement